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Conclusion: Strong correlations between predicted and 
achieved mean OAR doses indicates that RapidPlan could 
accurately predict achievable mean doses, showing the 
feasibility of using RapidPlan DVH predictions alone for 
automated individualized HNC plan QA. Since this QA 
approach does not require the creation of additional plans, 
these findings indicate that automated individualized plan QA 
is now a realistic proposition for individual centers and 
clinical trials. 
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Purpose or Objective: Image guided robotic stereotactic 
radiotherapy (SRT) is becoming increasingly commonly used 
in the treatment of prostate cancer. As SRT treatment may 
consist of 100-300 small beams, the dose-rate (DR) and thus 
the biologically effective dose (BED) can vary significantly 
within the target volume, despite the creation of a very 
uniform total physical dose distribution (1). However, the 
significance of the spatial variations in DR on BED in robotic 
SRT treatments remains unknown.  
The aim of the present study is to measure the DR 
distribution, with treatment progression, in a representative 
robotic SRT treatment for prostate cancer and to investigate 
the effect of these spatial and time related variations in the 
measured DR on the calculated BED. 
 
Material and Methods: A representative robotic SRT 
treatment plan for prostate cancer (5 x 7.25 Gy, 222 beams, 
treatment time 28 min) was created with the Multiplan 
treatment planning software (v 4.6.0., Accuray, USA). Based 
on this plan a quality assurance plan was calculated for a 
MultiCube phantom incorporating a MatriXX Detector (32 x 32 
matrix of ionization chambers) spatial resolution 7.6 mm, 
time resolution 0.5 s (IBA Dosimetry, Germany). The DR 
distributions were measured in four different coronal planes 
(separated by 1cm) covering the volume of the target 
structure to create a 3D DR distribution. Then BED values, 
calculated using bi-exponential repair (repair half times 0.2 h 
and 2.5 h, α/β =1.5Gy) were calculated for each voxel based 
on the measured DR (BED_M), average dose-rate (measured 
dose divided by the overall treatment time, BED_A) and 
physical dose (measured dose without the repair component, 
BED_P) distributions.  
 
Results: Compared to the BED_P, where no repair was 
allowed for, both BED_M and BED_A values, within the target 
volume, were significantly lower (Fig 1). Furthermore, BED_M 
values were found to be systematically higher than BED_A 
values. Significant variation was observed in BED_M values 
corresponding to the same BED_P value (Fig 1). This effect 
was not observed with BED_A values (Fig 1). 
 
 
 
Figure 1. A: Representative SRT plan, B: corresponding BED_P 
values, C: Frequency distributions of BED_P, BED_M and 
BED_A values within the target volume, D: Range of BED_M or 
BED_A values corresponding uniform BED_P value.  
 
Conclusion: The simple us of the average DR in the 
determination of BED does not take into account the 
variations in the spatial DR, and this leads to an 
underestimation of BED values. Furthermore, significant 
variations were observed in BED_M values when compared to 
uniform BED_P values, an observation also consistent with 
comparable Gamma Knife treatments (1). Thus, the actual 
and not the average DR should be used in the calculation of 
BED when the efficacy of the SRT treatments is evaluated or 
different treatment modalities are compared. 
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Learning Objectives 
 
At the end of this talkyou will have a better awareness of: 
1. reasons why educational ‘science’ may be overlooked 
2. how principles of adult learning might apply to radiation 
oncology 
3. potential benefits of applying an evidence-based approach 
to educationalactivities  
Radiation Oncology is adiscipline with a history firmly 
founded on the sciences of radiobiology,radiation physics, 
anatomy, pathology and clinical medicine that remain 
asrelevant as ever to its exciting future. An evidence-based 
approach to practiceand progress in our field is seen as core 
to our identity as radiation oncologyprofessionals. 
So how can it be thatthe ‘science’ of teaching the next 
generation of practitioners, as well as thecurrent one 
(ourselves), especially in such a rapidly changing arena, is 
oftenleft to chance? Why is so little focus placedon the 
